107 related articles for article (PubMed ID: 8689627)
1. Inhibition by verapamil of cholecystokinin-enhancement of pancreatic carcinogenesis induced by azaserine in Wistar rats.
Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
Cancer Lett; 1996 Jul; 105(1):23-7. PubMed ID: 8689627
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat.
Roebuck BD; Kaplita PV; Edwards BR; Praissman M
Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by neurotensin of azaserine-induced carcinogenesis in rat pancreas.
Tatsuta M; Iishi H; Baba M; Nakaizumi A
Int J Cancer; 1991 Feb; 47(3):408-12. PubMed ID: 1993548
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by galanin of experimental carcinogenesis induced by azaserine in rat pancreas.
Iishi H; Tatsuta M; Baba M; Yano H; Iseki K; Uehara H; Nakaizumi A
Int J Cancer; 1998 Jan; 75(3):396-9. PubMed ID: 9455800
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
[TBL] [Abstract][Full Text] [Related]
8. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by amiloride of experimental carcinogenesis induced by azaserine in rat pancreas.
Tatsuta M; Iishi H; Baba M; Yano H; Iseki K; Uehara H; Nakaizumi A
Cancer Lett; 1996 Aug; 106(1):23-8. PubMed ID: 8827043
[TBL] [Abstract][Full Text] [Related]
10. Effect of calcium channel blockers on gastric carcinogenesis and caerulein enhancement of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H; Taniguchi H
Cancer Res; 1990 Apr; 50(7):2095-8. PubMed ID: 2317798
[TBL] [Abstract][Full Text] [Related]
11. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
[TBL] [Abstract][Full Text] [Related]
13. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide.
Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma.
Zhou W; Povoski SP; Bell RH
Carcinogenesis; 1993 Oct; 14(10):2189-92. PubMed ID: 8222074
[TBL] [Abstract][Full Text] [Related]
15. Effect of tetragastrin on azaserine-induced carcinogenesis in rat pancreas.
Tatsuta M; Iishi H; Baba M; Nakaizumi A
Int J Cancer; 1990 Sep; 46(3):489-92. PubMed ID: 2144263
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas.
Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS
Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887
[TBL] [Abstract][Full Text] [Related]
17. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
[TBL] [Abstract][Full Text] [Related]
18. Azaserine-induced pancreatic foci: detection, growth, labelling index and response to raw soya flour.
Daly JM; Morgan RG; Oates PS; Yeoh GC; Tee LB
Carcinogenesis; 1992 Sep; 13(9):1519-23. PubMed ID: 1394834
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase (mu class) as an early marker of azaserine-induced foci in the rat pancreas.
Daly JM; Tee LB; Oates PS; Morgan RG; Yeoh GC
Carcinogenesis; 1991 Jul; 12(7):1237-40. PubMed ID: 1712677
[TBL] [Abstract][Full Text] [Related]
20. Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic preneoplastic lesions in the rat.
Thornton M; Moore MA; Ito N
Carcinogenesis; 1989 Feb; 10(2):407-10. PubMed ID: 2521462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
